Spring Co-Op: Immune Regulation in Oncology Research

Boehringer Ingelheim GmbH; Ridgefield (CT); On-site; USD 33,000 - 45,000; Full time

Benefits offered by this job

Medical insurance

Paid time off

Disability and life insurance

Job summary

Boehringer Ingelheim is seeking a Spring Co-Op for the Immune Regulation team in the Oncology Research department at Ridgefield, CT. The role focuses on collaborating on in vitro cancer immunology experiments to develop functional suppression assays that model the tumor microenvironment and translational platforms for evaluating immunomodulatory therapies.

You will work with scientists to establish and optimize assays, contribute to the understanding of immune cell activation, and gain exposure

Qualifications

• Must be a current Master’s or Ph.D. degree student in good academic standing.
• Student must be enrolled at an accredited college or university for the duration of the co-op.
• Overall GPA 3.0 on a 4.0 scale preferred.
• Major or minor in immunology, oncology, or cell biology.

Responsibilities

• Develop and refine tumor tissue dissociation protocols.
• Develop tumor microenvironment-mimetic immune suppression assays.
• Establish and optimize tumor cell killing assays.

Skills

Immunology

Oncology

Cell culture

In vitro assays

FACS

CRISPR

Teamwork

Communication

Education

Master's or PhD student

GPA 3.0+

Immunology/oncology related major

9 credit hours completed

Job description

Boehringer Ingelheim is seeking a Spring Co-Op for the Immune Regulation team in the Oncology Research department at Ridgefield, CT. The role focuses on collaborating on in vitro cancer immunology experiments to develop functional suppression assays that model the tumor microenvironment and translational platforms for evaluating immunomodulatory therapies.

You will work with scientists to establish and optimize assays, contribute to the understanding of immune cell activation, and gain exposure